Exozymes Inc. (EXOZ) stock
EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.83−0.17 (-4.25%)
Close on Nov 13, 2026Market cap $35.55MP/E –Yield –
Exozymes total assets
Total assets on the balance sheet at the end of each period.
Exozymes's total assets was $5.86M at Sep 30, 2026. For fiscal 2025 it was $5.97M, down 54.2% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.97M | -54.2% |
| FY2024 | Dec 31, 2024 | $13.03M | +266.3% |
| FY2023 | Dec 31, 2023 | $3.56M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.86M | -24.0% |
| Q2 FY2026 | Jun 30, 2026 | $7.98M | -17.5% |
| Q1 FY2026 | Mar 31, 2026 | $4.02M | -65.1% |
| Q4 FY2025 | Dec 31, 2025 | $5.97M | -54.2% |
| Q3 FY2025 | Sep 30, 2025 | $7.72M | +116.8% |
| Q2 FY2025 | Jun 30, 2025 | $9.68M | +171.9% |
| Q1 FY2025 | Mar 31, 2025 | $11.53M | – |
| Q4 FY2024 | Dec 31, 2024 | $13.03M | – |
| Q3 FY2024 | Sep 30, 2024 | $3.56M | – |
| Q4 FY2023 | Dec 31, 2023 | $3.56M | – |
See a number that looks wrong?